CASSANDRA FORADORI: Open Payments
NPI 1437740800 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,243 in 251 payments from 22 companies in 2025. Trend: 2023 $3,945 · 2024 $4,068 · 2025 $4,243
Food & beverage: $4,211Speaker / faculty: $31
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 84 | $876 |
| Neurocrine BioSciences, Inc. | 13 | $415 |
| ACADIA Pharmaceuticals Inc | 12 | $360 |
| ABBVIE INC. | 19 | $357 |
| Genentech USA, Inc. | 13 | $253 |
| MDD US Operations, LLC | 7 | $246 |
| Lundbeck LLC | 22 | $245 |
| UCB, Inc. | 11 | $218 |
| Axsome Therapeutics, Inc. | 6 | $215 |
| Biogen, Inc. | 13 | $193 |
Products named: AUSTEDO XR, INGREZZA, NUPLAZID, VYEPTI, Symbravo, TYSABRI, VYVGART HYTRULO, Ocrevus.
Industry payments across PA — which companies pay providers there.
